Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04593693 · ClinicalTrials.gov registry record · NA
A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System
A NA study, sponsored by Medela.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04593693: Completed NA study, sponsored by Medela.
NCT04593693 is a NA study that has completed, run by Medela. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04593693, a NA study, has completed, sponsored by Medela.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
Primary Outcome
Wound measurements will be performed each week and length, width and depth of the wound measured during treatment until goal of the therapy is reached
Interventions
- DEVICE Invia Motion Endure NPWT system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2021-05-18 |
| Phase | NA |
What the finished NCT04593693 record still lists
NCT04593693 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Invia Motion Endure NPWT system is the first listed.
NCT04593693 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04593693 about?
NCT04593693 is a clinical study titled "A Dual-center Study Evaluating Clinical Acceptance of a NPWT Wound Care System". The purpose of this study is to determine if use of the Medela Invia Motion NPWT system supports acceptable progress towards the goal of therapy when treating patients with a variety of wound types during the evaluation period.
What is the current status of trial NCT04593693?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2020-12-10. Estimated completion is 2021-05-18.
What interventions are being tested in trial NCT04593693?
The interventions under investigation include: Invia Motion Endure NPWT system (DEVICE).
Who is sponsoring clinical trial NCT04593693?
This trial is sponsored by Medela, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04593693's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI